Management of hepatitis C virus infection in HIV/HCV co-infected patients: Clinical review

doi:10.3748/wjg.15.3713

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4249)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-6) series.

Item

Count

PDF

401

HTML

3410

Figures (1-3)

194

Tables (1-6)

244

Sum=4249

Aug 14, 2009 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (36)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Aug 14, 2009; 15(30): 3713-3724
Published online Aug 14, 2009. doi: 10.3748/wjg.15.3713

Table 3 Barriers against anti-HCV therapy in co-infected patients

Patient-related factors

Active substance abuse

Concern regarding adverse effects

Cost of treatment

Lack of social support

Lack of transport

Number of pills and dosing frequency (including HAART)

Physician-related factors

Lack of experience

Lack of awareness

Lack of motivation for referral

Fear of adverse effects

HAART: Highly active anti-retroviral therapy.

Citation: Singal AK, Anand BS. Management of hepatitis C virus infection in HIV/HCV co-infected patients: Clinical review. World J Gastroenterol 2009; 15(30): 3713-3724
URL: https://www.wjgnet.com/1007-9327/full/v15/i30/3713.htm
DOI: https://dx.doi.org/10.3748/wjg.15.3713